IceCure Medical Ltd Stock TEL AVIV STOCK EXCHANGE
Stocks
ICCM
IL0011224156
Advanced Medical Equipment & Technology
| Market Cap | 7.88M 0 6.79M 6.37M 5.81M 10.95M 753M 10.99M 75.55M 29.48M 380M 29.59M 28.95M 1.26B | P/E 2026 * |
-0.41x | P/E 2027 * | -0.67x |
|---|---|---|---|---|---|
| Enterprise Value | 7.88M 0 6.79M 6.37M 5.81M 10.95M 753M 10.99M 75.55M 29.48M 380M 29.59M 28.95M 1.26B | EV / Sales 2026 * |
1.84x | EV / Sales 2027 * | 0.9x |
| Free-Float |
54.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : IceCure Medical Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Eyal Shamir
CEO | Chief Executive Officer | 65 | 01/09/2016 |
Meir Peleg
DFI | Director of Finance/CFO | 50 | 17/05/2026 |
Shay Levav
COO | Chief Operating Officer | 49 | 05/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Eyal Shamir
BRD | Director/Board Member | 65 | 05/12/2017 |
| Chairman | 62 | 05/12/2017 | |
Sharon Levita
BRD | Director/Board Member | 57 | 01/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -6.22% | - | - | 7.85M | |
| -1.35% | -1.13% | +27.04% | +14.12% | 233B | |
| +0.18% | -1.27% | +5.25% | -17.37% | 152B | |
| +1.51% | -1.64% | -21.37% | +23.59% | 130B | |
| +0.36% | -7.01% | -55.71% | -12.92% | 67.64B | |
| +0.29% | +0.47% | +11.06% | +18.65% | 51.85B | |
| +0.66% | -1.69% | -16.57% | -13.62% | 50.91B | |
| -2.44% | -3.25% | +23.11% | +28.29% | 44.46B | |
| -1.56% | +0.97% | +39.32% | +47.34% | 41.39B | |
| +1.94% | +3.81% | -12.73% | +48.46% | 34.01B | |
| Average | -0.06% | -0.84% | -0.07% | +15.17% | 89.42B | |
| Weighted average by Cap. | -0.18% | -1.28% | +3.13% | +9.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.3M 0 3.7M 3.47M 3.17M 5.97M 410M 5.99M 41.17M 16.06M 207M 16.13M 15.77M 687M | 8.8M 0 7.59M 7.11M 6.49M 12.23M 841M 12.27M 84.38M 32.92M 425M 33.05M 32.33M 1.41B |
| Net income | -17.66M -0 -15.22M -14.27M -13.02M -24.53M -1.69B -24.61M -169M -66.04M -852M -66.29M -64.85M -2.82B | -16.34M -0 -14.08M -13.2M -12.05M -22.7M -1.56B -22.77M -157M -61.1M -788M -61.33M -60M -2.61B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
